Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Pharmacogenet Genomics. 2011 Apr;21(4):185–196. doi: 10.1097/FPC.0b013e32833eecbc

Figure 2.

Figure 2

(A) Percent methylation of 10 CpG dinucleotides (# 3–12) in the PDYN promoter CpG island in two brain regions, the caudate and anterior cingulate cortex. (B) When stratified by HIV status, there was no difference in percent methylation of the CpG sites between HIV positive and HIV negative subjects. Methylation levels at each CpG site in each tissue are shown as mean ± SEM.